Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
LLY | Eli Lilly and Company | 66.9 | ¤728,809 | US |
NOVO.B.DK | Novo Nordisk A/S Class B | 72.6 | ¤215,776 | DK |
MRK | Merck & Co., Inc. | 62.0 | ¤200,531 | US |
ISRG | Intuitive Surgical, Inc. | 63.4 | ¤173,273 | US |
AMGN | Amgen Inc. | 62.2 | ¤162,355 | US |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
SRPT | Sarepta Therapeutics, Inc. | 27.0 | ¤1,681 | US |
LNTH | Lantheus Holdings Inc | 61.5 | ¤4,944 | US |
SFZN.CH | Siegfried Holding AG | 53.1 | ¤4,960 | CH |
HLUN.B.DK | H. Lundbeck A/S Class B | 69.9 | ¤5,198 | DK |
326030.KR | SK Biopharmaceuticals Co., Ltd. | 71.6 | ¤5,435 | KR |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
NOVO.B.DK | Novo Nordisk A/S Class B | 72.6 | 36 | DK |
BIIB | Biogen Inc. | 59.5 | 30 | US |
AMGN | Amgen Inc. | 62.2 | 29 | US |
ISRG | Intuitive Surgical, Inc. | 63.4 | 25 | US |
REGN | Regeneron Pharmaceuticals, Inc. | 58.3 | 23 | US |
RMD | ResMed Inc. | 73.0 | 23 | US |
EW | Edwards Lifesciences Corporation | 46.7 | 22 | US |
LLY | Eli Lilly and Company | 66.9 | 21 | US |
4507.JP | Shionogi & Co., Ltd. | 68.2 | 20 | JP |
4519.JP | Chugai Pharmaceutical Co., Ltd. | 61.0 | 19 | JP |
Average Market Cap | ¤53,754 |
Median Market Cap | ¤14,231 |
Avg. 3 Mo. Dollar Vol. | ¤327,494,773 |
Avg. 3 Mo. Trading Vol. | 3,730,246 |
Last Rebalance Date | 03/24/2025 |
Companies Replaced | 16 |
Biggest Industry Increase | Pharmaceuticals: Major |
Biggest Industry Decrease | Medical Specialties |
Trailing P/E Ratio (12 Mo.) | 21.8 |
Forward P/E Ratio (12 Mo.) | 19.8 |
Price/Book Ratio | 4.7 |
Avg. Revenue Chg. - 3 Yr | 40.9% |
Avg. Op. Income Chg. - 3 Yr. | 53.6% |
Avg. EPS Growth - 3 Yr. | 15.9% |
Avg. EPS Growth - 1 Yr. | 10.7% |
Avg. Operating Margin | 23.6% |
Avg. LT Debt to Total Capital | 33.3% |
Avg. Return on Equity | 19.3% |
Dividend Yield | 0% |
Developed Markets (ex-Australia) Health Care Index | 61.49 |
United States Of America | 68.0% |
Japan | 12.0% |
Denmark | 8.0% |
Korea, Republic Of | 4.0% |
Sweden | 2.0% |
Finland | 2.0% |
Ireland | 2.0% |
Switzerland | 2.0% |